Global Pneumococcal Polysaccharide Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Pneumococcal Polysaccharide Vaccine market report explains the definition, types, applications, major countries, and major players of the Pneumococcal Polysaccharide Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • China National Biotec Group

    • Pfizer Inc

    • Serum Institute of India Pvt Ltd

    • Merck & Co Inc

    • Glaxosmithkline Plc

    • Astellas Pharma Inc

    • Sanofi Pasteur

    By Type:

    • Single Dose Vial

    • Pre-Filled Syringe

    By End-User:

    • Children (2-10 Age)

    • Adult (10-64 Age)

    • Geriatric (More Than 65 Age)

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Pneumococcal Polysaccharide Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Pneumococcal Polysaccharide Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Pneumococcal Polysaccharide Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Pneumococcal Polysaccharide Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Pneumococcal Polysaccharide Vaccine Market- Recent Developments

    • 6.1 Pneumococcal Polysaccharide Vaccine Market News and Developments

    • 6.2 Pneumococcal Polysaccharide Vaccine Market Deals Landscape

    7 Pneumococcal Polysaccharide Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials

    • 7.2 Pneumococcal Polysaccharide Vaccine Price Trend of Key Raw Materials

    • 7.3 Pneumococcal Polysaccharide Vaccine Key Suppliers of Raw Materials

    • 7.4 Pneumococcal Polysaccharide Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Pneumococcal Polysaccharide Vaccine Cost Structure Analysis

      • 7.5.1 Pneumococcal Polysaccharide Vaccine Raw Materials Analysis

      • 7.5.2 Pneumococcal Polysaccharide Vaccine Labor Cost Analysis

      • 7.5.3 Pneumococcal Polysaccharide Vaccine Manufacturing Expenses Analysis

    8 Global Pneumococcal Polysaccharide Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Pneumococcal Polysaccharide Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Pneumococcal Polysaccharide Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Single Dose Vial Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pre-Filled Syringe Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children (2-10 Age) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult (10-64 Age) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Geriatric (More Than 65 Age) Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.2 UK Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.5 France Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.3 India Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    11 Global Pneumococcal Polysaccharide Vaccine Competitive Analysis

    • 11.1 China National Biotec Group

      • 11.1.1 China National Biotec Group Company Details

      • 11.1.2 China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.1.4 China National Biotec Group Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Pfizer Inc

      • 11.2.1 Pfizer Inc Company Details

      • 11.2.2 Pfizer Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Pfizer Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.2.4 Pfizer Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Serum Institute of India Pvt Ltd

      • 11.3.1 Serum Institute of India Pvt Ltd Company Details

      • 11.3.2 Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.3.4 Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck & Co Inc

      • 11.4.1 Merck & Co Inc Company Details

      • 11.4.2 Merck & Co Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck & Co Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.4.4 Merck & Co Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Glaxosmithkline Plc

      • 11.5.1 Glaxosmithkline Plc Company Details

      • 11.5.2 Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.5.4 Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Astellas Pharma Inc

      • 11.6.1 Astellas Pharma Inc Company Details

      • 11.6.2 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.6.4 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sanofi Pasteur

      • 11.7.1 Sanofi Pasteur Company Details

      • 11.7.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

      • 11.7.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Pre-Filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Children (2-10 Age) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adult (10-64 Age) Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Geriatric (More Than 65 Age) Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Pneumococcal Polysaccharide Vaccine

    • Figure of Pneumococcal Polysaccharide Vaccine Picture

    • Table Global Pneumococcal Polysaccharide Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Pneumococcal Polysaccharide Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Single Dose Vial Consumption and Growth Rate (2017-2022)

    • Figure Global Pre-Filled Syringe Consumption and Growth Rate (2017-2022)

    • Figure Global Children (2-10 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Adult (10-64 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Geriatric (More Than 65 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Table North America Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure United States Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Germany Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure China Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure Australia Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table China National Biotec Group Company Details

    • Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Pfizer Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Serum Institute of India Pvt Ltd Company Details

    • Table Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Merck & Co Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Glaxosmithkline Plc Company Details

    • Table Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Astellas Pharma Inc Company Details

    • Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Table Sanofi Pasteur Company Details

    • Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Main Business and Markets Served

    • Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio

    • Figure Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pre-Filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children (2-10 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult (10-64 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Geriatric (More Than 65 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.